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Abstract
Disclosure of HIV serostatus to sexual partners is mandated within certain states in the United 
States and other countries. Despite these laws implemented and public health efforts to increase 
disclosure, rates of disclosure to sexual partners among people living with HIV (PLWH) remain 
low, suggesting the need for interventions to assist PLWH with the disclosure process. We 
conducted a systematic review of studies testing whether HIV serostatus disclosure interventions 
increase disclosure to sexual partners. We searched six electronic databases and screened 484 
records. Five studies published between 2005 and 2012 met inclusion criteria and were included in 
this review. Results showed that three of the HIV serostatus disclosure-related intervention studies 
were efficacious in promoting disclosure to sexual partners. Although all three studies were 
conducted in the United States the intervention content and measurements of disclosure across the 
studies varied, so broad conclusions are not possible. The findings suggest that more rigorous HIV 
serostatus disclosure-related intervention trials targeting different populations in the United States 
and abroad are needed to facilitate disclosure to sexual partners.
Introduction
Disclosing one’s HIV-positive serostatus can have benefits for both individuals infected with 
HIV and public health prevention efforts. For example, HIV serostatus disclosure can lead to 
social support, closeness in relationships, antiretroviral therapy initiation and adherence, 
psychological and physical wellbeing for people living with HIV (PLWH) [1-8]. From a 
public health perspective, disclosure of HIV serostatus is also vital because it allows sexual 
partners the opportunity to seek HIV testing and communicate about safer-sex practices, 
which can increase condom use and lead to an estimated 61 % reduction in the risk of HIV 
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to-child transmission (PMTCT), as HIV-positive pregnant women who disclose to their 
sexual partners have more assistance to successfully follow the PMTCT requirements 
[14-17]. However, there are a number of potential negative consequences such as HIV-
related stigma, discrimination, blame, loss of economic support, abandonment, physical and 
emotional abuse, that make HIV serostatus disclosure unsafe, especially for women [4, 16, 
18-20]. These negative consequences have served as barriers of HIV serostatus disclosure 
and led to behaviors that place uninfected sexual partners at risk for HIV transmission 
[21-23].
To date, most researchers have employed cross sectional survey methods to examine rates of 
HIV serostatus disclosure to sexual partners and the factors associated with the process. 
Based on recent studies, rates of HIV sero-status disclosure to sexual partners range from 
97 % in South Africa [24], 89 % in the United States [25], 86 % in Brazil [26] to 73 % in 
Canada [27], and 39 % in Haiti [28]. The characteristics contributing to low rates of 
disclosure to sexual partners in some regions of the world have been found to be related to 
shorter length of time since HIV diagnosis, HIV-related stigma, having multiple sexual 
partners, partners of HIV negative or unknown status, not receiving antiretroviral treatment, 
emotional distress, low disclosure self-efficacy, and unemployment due to HIV status [22, 
28-33]. In an effort to further understand the reasons and approaches PLWH use to disclose 
or not disclose their HIV serostatus to sexual partners, a number of researchers have 
employed qualitative methods to explore the disclosure process among different groups 
including but not limited to adolescents, adult men and women, and men who have sex with 
men (MSMs) [19, 34-45].
For PLWH who have decided to disclose to a sexual partner, qualitative studies indicate that 
the most common motivators for disclosure are the risk of HIV infection and encouraging 
their sexual partner to test for HIV [36, 46]. Other qualitative research suggest that 
adolescents with perinatally acquired HIV who are deciding whether to disclose to their 
partners face barriers related to lack information and skills about how to disclose their HIV 
serostatus to sexual partners [47, 48]. Similarly, qualitative research conducted among 
women report that although they are aware of the benefits of disclosing their status to sexual 
partners, the fear of abandonment, violence and being blamed for bringing HIV to the family 
prevent them from sharing their status with their partners [49-52]. These findings are 
consistent for adult males and adolescents who do not disclose their HIV serostatus to sexual 
partners in fear of being stigmatized [48, 53-56].
Given the potential benefits of HIV serostatus disclosure to sexual partners and the 
challenges PLWH face when deciding how, and when to disclose to sexual partners, it is 
clear that there is an ongoing need to support PLWH with the process. In order to improve 
rates of disclosure globally, it is necessary to examine the effectiveness of the existing 
interventions aimed at increasing disclosure to sexual partners. Although a number of 
reviews have been published on HIV serostatus disclosure to sexual partners, they have only 
examined characteristics related to disclosure and the process of disclosure as opposed to 
interventions developed to facilitate disclosure to sexual partners [16, 57, 58]. This paper 
aims to fill an important gap by providing a systematic review and synthesis of interventions 
designed to promote HIV serostatus disclosure to sexual partners.
Conserve et al. Page 2















We searched the following databases for peer reviewed articles reporting on HIV/AIDS 
disclosure interventions for all types of individuals anywhere in the world: Pubmed, 
Embase, PsycInfo, PsycArticles, Academic Search Complete, and Global Health. Keywords 
for the search included HIV/AIDS; disclosure; serostatus; interventions; comparison; trials. 
All articles (n = 484) were initially screened by two reviewers who independently reviewed 
the titles and abstracts of studies to accept or reject for full text review. Abstracts were 
rejected if the studies did not have [1] interventions promoting HIV serostatus disclosure to 
sexual partners [2] an HIV disclosure outcome measure, and [3] an experimental or quasi-
experimental study design. All studies yielded through the search terms described above 
were published before February 2014.
Full Text Review
The same two reviewers independently reviewed the full texts of the studies identified from 
the electronic search to determine if they were still eligible to undergo data extraction. In 
order to be included, studies had to evaluate an intervention designed to promote HIV 
serostatus disclosure to sexual partners among any groups anywhere in the world. Data were 
extracted from eligible studies into an electronic spreadsheet. Reviewers discussed any 
disagreements in the data extracted, and referral to a third reviewer was done to resolve any 
disputes. We extracted the following data: study characteristics (authors, publication date, 
study sample, study location, type of study design, comparison group, outcome measures); 
and intervention characteristics (types of intervention strategies used and outcomes). We 
divided the interventions into two types: [1] group and peer-led approaches, and [2] online 
approaches.
Results
Inclusion and Exclusion of Studies
The electronic database searches retrieved 484 records (124 from Embase, 357 from 
Pubmed, and 3 from Ebsco). After removing the duplicates in RefWorks, 415 records were 
screened (Fig. 1). Of these, 388 were excluded because they were descriptive studies that 
only examined factors related to HIV serostatus disclosure but did not evaluate an 
intervention to promote HIV serostatus disclosure to sexual partners. Twelve records were 
excluded because they were court cases related to HIV disclosure. Fifteen records were 
selected at the abstract level for full text review because they described an intervention 
designed to promote HIV serostatus disclosure. Ten of the 15 studies that initially appeared 
to meet the inclusion criteria were later excluded after full text review. Seven of those 
reported on an HIV disclosure-related intervention but they did not include disclosure to a 
sexual partner as their outcome. Rather, outcomes for these studies were disclosure intention 
[59] disclosure efficacy and anxiety [60], disclosure to children [61, 62] or disclosure to any 
adults in their social network [63-65]. The remaining three studies were excluded because 
they did not use an experimental or quasi experimental design [66-68].
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Description of Included Studies
The final sample consisted of five studies published between 2005 and 2012, each of which 
evaluated an intervention designed to promote HIV serostatus disclosure to sexual partners 
(Table 1). The sample size for these studies ranged from 77 participants [69] to 1,631 
participants [70]. There was little variation in study population across the five studies. The 
target group for nearly all of the intervention studies was MSM; only one study targeted a 
different population (minority women). Although the search was not limited to any 
geographical location, all of the studies that met the inclusion criteria for this review were 
conducted in the United States. Unlike the other three intervention studies that included only 
HIV-positive participants, Chiasson et al. 2009 and Hirsfield et al. 2012 recruited both HIV-
positive and HIV-negative individuals [70, 71].
Intervention Theoretical Framework and Design
All the studies selected for this review included a theory-based intervention to improve HIV 
serostatus disclosure to sexual partners. Serovich et al. 2009 employed the consequences 
theory of disclosure which purports that disclosure occurs once the rewards for disclosing 
outweigh associated costs [69]. Teti et al. 2010 used tenets of the Transtheoretical Model of 
the Stages of Change, the Modified AIDS Risk Reduction Model, and the Theory of Gender 
and Power [72]. Wolitsky et al. 2005 applied a number of behavioral theories including the 
Information-Motivation-Behavioral skills model of AIDS risk reduction, Social Cognitive 
Theory, and the Theory of Planned Behavior [73]. The online interventions (Chiasson et al. 
2009; Hirshfield et al. 2012) were informed by developmental, social, and cognitive-
constructivist learning theories [70,71].
Four studies used randomized controlled trials (RCTs) and one used a pretest/posttest single-
arm design. There was variation in the number of study arms across the RCTs. Serovich et 
al. 2009 used a three-arm crossover design to compare a facilitator-only group session 
condition, a computer and facilitator condition, and a wait-list control condition [69]. Teti et 
al. 2010 used a two-arm design to compare a control group and a treatment group [72]. 
Wolitsky et al. 2005 used a two-arm design to compare an enhanced peer-led intervention to 
a one session standard-of-care [73]. Hirshfield et al. 2012 used a five-arm design and 
Chiasson et al. 2009 used a single group pre-test/posttest study [70, 71].
Intervention Content and Disclosure Measurement
Intervention contents varied from attending weekly support groups to viewing online videos. 
The pilot group support intervention for HIV-positive individuals by Serovich et al. 2009 
was tested using a three-arm design (waitlist control, facilitator only, and computer and 
facilitator) and consisted of four weekly sessions without booster sessions [69]. Participants 
in the facilitator group completed all intervention activities face-to-face while participants in 
the computer-and-facilitator group completed initial assessment and paper-and-pencil 
exercises electronically and the remaining activities with a facilitator. The topics covered 
during the four sessions for each of the groups were related to strategies for disclosure, cost 
and benefits of disclosure, and evaluation of different disclosure strategies [69]. In the two-
arm design study conducted by Teti et al. 2010, there were three components to the 
intervention [72]. In the first part, participants in the treatment group received prevention 
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messages during their regularly scheduled clinic visits from healthcare professionals (nurses 
or physicians) who were trained in a 4-h training and quarterly booster sessions [72]. In the 
second part, participants attended five weekly 1.5 h group sessions to learn about safer sex, 
women’s challenges and opportunities, HIV/AIDS and STI facts, condom use and 
negotiation, HIV status disclosure, problem solving, healthy relationships, and goal setting. 
Participants who completed the second part of the intervention were eligible to attend 1-h 
weekly support group conducted by peer educators designed to help participants learn how 
to discuss condom use with their partners [72].
Wolitsky et al. 2005 evaluated a peer-led intervention for HIV-positive gay and bisexual men 
in a two-arm randomized study [73]. Participants in the treatment group attended six weekly 
3-h sessions focusing on relationships, HIV and STI transmission, drug and alcohol use, 
HIV status of sex partners, HIV status disclosure, and mental health without booster sessions 
[73]. The two online interventions (Chiasson et al. 2009; Hirshfield et al. 2012) included 
HIV+ and HIV− individuals recruited from popular gay-oriented sexual networking websites 
[70, 71]. Chiasson et al. 2009 tested a nine-minute dramatic HIV prevention video in a one 
group pre-test post-test design [71]. Hirshfield et al. 2012 evaluated a five-arm intervention 
in which participants received the following conditions without a booster session: (1) 
dramatic video; (2) documentary video; (3) both dramatic and documentary videos; (4) 
prevention webpage; (5) control (no intervention content) [70]. The videos, and prevention 
webpage were designed to promote critical thinking about HIV disclosure, HIV testing, and 
condom use [70].
Disclosure was measured differently across the studies and disclosure was assessed between 
2 and 18 months after implementation of the interventions. Serovich et al. 2009 used three 
13-item scales to measure mean scores of disclosure behaviors to casual sex partners [69]. 
Teti et al. 2010 measured partner disclosure by dividing the number of partners to whom 
participants had disclosed by the number of partners they had in the past 6 months [72]. 
Wolitsky et al. 2005 assessed serostatus disclosure separately for new and existing partners 
and created a three category measure that measured whether participants disclosed to all, 
some, or none of their sex partners [73]. The two online interventions (Chiasson et al. 2009; 
Hirshfiled et al. 2012) measured partial (i.e. asking or telling) and full (i.e. both asking and 
telling) disclosure [70, 71].
Summary of Study Findings
Intervention impact was mixed across the studies. Serovich et al. 2009 found a positive 
effect on disclosure behavior scores at 3 months follow-up for the facilitator-only group 
[69]. However, there was no effect in the computer and facilitator group in comparison to the 
wait-list control. Teti et al. 2010 reported an increase in disclosure at 6-, 12-, and 18-months 
follow-up but these disclosure rates never reached a statistically significant difference [72]. 
Similarly, Wolitsky et al. 2005 reported that no significant differences were found between 
the intervention condition and the control group in the proportion of sex partners disclosed 
to or in the percentage of men reporting sex with a new sex partner who was unaware of the 
participant’s HIV status at 3-, and 6-months follow-up [73]. The online interventions 
showed a positive effect at 3-months follow-up for the pre-test posttest single group design 
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[71], and 2-months follow-up for the randomized controlled trial, showing participants who 
received the pooled dramatic and documentary intervention more likely to report partial 
(“asking”) and full disclosure (“asking and telling”) than those in the control group [70].
Discussion
The objective of this paper was to conduct a systematic review of interventions designed to 
promote HIV serostatus disclosure to sexual partners among PLWH. Our findings revealed 
that only a small number of studies have evaluated an intervention aiming to increase 
disclosure to sexual partners. Furthermore, the five intervention studies included in this 
review had other primary outcome measures such as HIV testing, and condom use, 
indicating that interventions focusing strictly on HIV serostatus disclosure to sexual partners 
are needed. The five HIV serostatus disclosure-related intervention studies were all 
conducted in the United States and the target group for nearly all of the intervention studies 
were MSM; only one study reviewed targeted a different population (and their focus was 
minority women). The findings of the interventions were mixed, with three (Serovich et al. 
2009; Chiasson et al. 2009; Hirsfield et al. 2012) out of the five studies showing that 
participating in a disclosure-related intervention program significantly increased disclosure 
to sexual partners among MSMs [69-71]. Although three of the interventions were 
efficacious in promoting HIV serostatus, their findings must be interpreted with caution.
There was considerable variation in intervention content across the three efficacious 
interventions. Specifically, the first intervention (Serovich et al. 2009) consisted of four 
weekly support groups session using an RCT three-arm design, comparing a facilitator-only 
group session condition, a computer and facilitator condition, and a wait-list control whereas 
the other two interventions (Chiasson et al. 2009; Hirshfield et al. 2012) consisted of online 
delivered interventions using a single-arm and five-arm design to compare groups that 
viewed a dramatic HIV prevention video, documentary HIV prevention video, both the 
dramatic and documentary HIV prevention videos, HIV prevention web page, and a control 
group that received no intervention content [69-71]. Although there was a positive effect in 
the first intervention (Serovich et al. 2009) on disclosure to casual sexual partners among 
MSMs in the facilitator-only group, the computer-and-facilitator group was not statistically 
different from the control group [69]. One explanation offered for this finding is the 
preference of the participant to meet face to face with someone and verbally discuss their 
obstacles in the facilitator-only group.
Both of the interventions (Chiasson et al. 2009; Hirshfield et al. 20102) delivered online 
were efficacious at increasing HIV serostatus disclosure [70, 71]. However, it must be noted 
that perhaps the reason the online studies found a significant increase in disclosure was 
because the majority of the participants were HIV-negative. For example, of the 522 men 
who completed the first online intervention (Chiasson et al. 2009), only 72 were HIV-
positive and in the other online intervention (Hirsfield et al. 2009) only 532 out of 3,092 
respondents were HIV-positive. Since the barriers to HIV serostatus disclosure to sexual 
partners that PLWH face are different from HIV uninfected individuals, future intervention 
studies promoting HIV serostatus disclosure online should target HIV-positive participants.
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The findings of the remaining two disclosure-related interventions (Wolitsky et al. 2005; Teti 
et al. 20120) were non-significant [72, 73]. It is possible that these non-significant findings 
were due to the content of the interventions themselves. On the other hand, researchers 
identified other potential issues that may have contributed to the non-significant findings. 
Some of the reasons Teti et al. 2010 reported for the lack of significance were reduced 
sample size due to attrition and the manner in which disclosure was measured [72]. An 
additional reason potentially limiting the effect of the interventions was the fact that the 
interventions had multiple goals such as decreasing sexual partners, and unprotected 
intercourse as opposed to focusing solely on promoting HIV serostatus disclosure to sexual 
partners [72, 73]. Regarding the study focusing on minority women, Teti et al. 2010 suggest 
the findings were non-significant due to the fact that the intervention did not remove or 
sufficiently address the risks associated with women’s HIV serostatus disclosure such as 
abandonment, stigma, discrimination, and violence [72].
More research and standardized interventions are needed to promote disclosure to sexual 
partners. Among the disclosure-related intervention studies included in this review, there 
was significant variation across the studies in terms of setting, sampling, study design, 
definition of outcome and intervention content. The small numbers of studies included in the 
review, combined with variation across these studies, prevent us from making broad 
conclusions about the efficacy of existing interventions focusing on promoting disclosure to 
sexual partners. Rather, they point to a pressing need for additional research on how to 
promote disclosure among a much broader range of populations and settings.
First, the fact that only five interventions were included and they were all conducted in the 
United States indicates the urgent need to implement and evaluate more disclosure-related 
interventions focusing on sexual partners. Regarding the small number of included studies in 
this review it is plausible that there are more interventions that have been implemented to 
promote HIV serostatus disclosure to sexual partners but they have not been quantitatively 
evaluated and published in a peer review journal. For example, Maiorana et al. 2012 
describes qualitative findings of patients’ response regarding disclosure messages they 
received as part of a number of prevention with positives interventions conducted in clinical 
settings throughout the United States but does not offer quantitative findings regarding 
disclosure rates to sexual partners among the participants [74]. Similarly, interventions 
related to HIV serostatus disclosure have been conducted in sub-Saharan Africa (Kaaya et 
al. 2013; Mundell et al. 2011), however, they were excluded from our systematic review 
because they did not measure disclosure rates to sexual partners. Two of the disclosure-
related intervention studies conducted in sub-Saharan Africa were excluded from the current 
review because they only measured disclosure to anyone within the participants’ social 
networks [63, 64]. While disclosure to broader networks is an important goal for the 
psychosocial well-being of PLWH, disclosure to sexual partners is crucial for initiating 
communications about safe sex. In addition, two other interventions focusing on disclosure 
to sexual partners in sub-Saharan Africa did not meet our inclusion criteria due to weak 
study designs [59, 66]. Given the potential of HIV serostatus disclosure to sexual partners to 
prevent new HIV infections, there is a dire need to develop, implement, and evaluate 
rigorous disclosure-related intervention studies in areas with high HIV prevalence.
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Second, although the studies included in this review were conducted in the United States 
they do not represent all groups and regions. For example, the included studies focused 
mostly on MSMs, with the exception of one study that included minority women. Future 
research and interventions regarding disclosure to sexual partners in the United States and 
other developed countries should target different population groups such as immigrants and 
ethnic minorities [1, 6, 75, 76]. Communication within sexual partnerships may differ across 
these different sub-populations, and interventions may need to be tailored accordingly. 
Third, future research should discern whether there are differences in patterns of disclosure 
across high and low prevalence settings or differences in patterns of disclosure across 
different sub-populations. For example, it is possible that pregnant women in sub-Saharan 
Africa face different barriers to disclosing their status than pregnant women in the United 
States. Understanding these differences may contribute to the development of intervention 
tailored specifically to the context and population at hand.
In the ongoing fight against the spread of HIV, there continues to be a pressing need for 
interventions that successfully support individuals through the process of disclosing their 
HIV serostatus to their sexual partner. Nonetheless, it is critical to remember that there will 
always be individuals and populations for which disclosure is not a safe or recommended 
behavior. As such, it is imperative that disclosure-related researchers and interventionists 
continuously monitor the potential risks and outcomes of disclosure so that HIV-positive 
individuals confer the benefits of disclosure without experiencing harm during the process.
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